TG | Thyroglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
NKX2-1 | NK2 homeobox 1 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
SLC5A5 | Solute carrier family 5 (sodium/iodide cotransporter), member 5 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
TPO | Thyroid peroxidase | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
IYD | Iodotyrosine deiodinase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ZMAT4 | Zinc finger, matrin-type 4 | Predicted intracellular proteins
| | | | | Group enriched |
ATF5 | Activating transcription factor 5 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
LRP2 | Low density lipoprotein receptor-related protein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
PDE8B | Phosphodiesterase 8B | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
SLITRK5 | SLIT and NTRK-like family, member 5 | Predicted membrane proteins
| | | | | Group enriched |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Group enriched |
C16orf89 | Chromosome 16 open reading frame 89 | Predicted secreted proteins
| | | | | Group enriched |
DIO2 | Deiodinase, iodothyronine, type II | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PAX8 | Paired box 8 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
DOCK3 | Dedicator of cytokinesis 3 | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
SORBS2 | Sorbin and SH3 domain containing 2 | Predicted intracellular proteins
| | | | | Group enriched |
TCFL5 | Transcription factor-like 5 (basic helix-loop-helix) | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
AFAP1L2 | Actin filament associated protein 1-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDON | Cell adhesion associated, oncogene regulated | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
CMTM4 | CKLF-like MARVEL transmembrane domain containing 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
CNTN5 | Contactin 5 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FNDC1 | Fibronectin type III domain containing 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GLIS3 | GLIS family zinc finger 3 | Disease related genes Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
GPR61 | G protein-coupled receptor 61 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ID4 | Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ITGB3 | Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KCNAB1 | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCTD8 | Potassium channel tetramerization domain containing 8 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KLHL14 | Kelch-like family member 14 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KRT7 | Keratin 7 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NPM2 | Nucleophosmin/nucleoplasmin 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NPNT | Nephronectin | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
PDE1A | Phosphodiesterase 1A, calmodulin-dependent | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PRKX | Protein kinase, X-linked | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PRTG | Protogenin | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RAB43 | RAB43, member RAS oncogene family | Predicted intracellular proteins
| | | | | Tissue enhanced |
RAP1GAP | RAP1 GTPase activating protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
RNF165 | Ring finger protein 165 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RPS6KA6 | Ribosomal protein S6 kinase, 90kDa, polypeptide 6 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
SALL4 | Spalt-like transcription factor 4 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
SHISA2 | Shisa family member 2 | Predicted membrane proteins
| | | | | Tissue enhanced |